Inventor · disambiguated record
Kodandaram Pillarisetti
Also filed as: PILLARISETTI KODANDARAM
5 granted patents·5 pending applications·63 citations·filing 1998–2025
80Inventor score
Top patents by PatentIndex Score
10 records- 0195US10072088B2Anti-BCMA antibodies and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Sep 11, 2018·30 cites·16 claims
- 0292US10562968B2Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Feb 18, 2020·18 cites·19 claims
- 0389US11884722B2Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereofJANSSEN BIOTECH INC·Filed 2023·Granted Jan 30, 2024·1 cites·25 claims
- 0481US11685777B2Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Jun 27, 2023·1 cites·9 claims
- 0578US2024343796A1Anti- gprc5d antibodies, bispecific antigen binding molecules that bind gprc5d and cd3, and uses thereofJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 0669US2025362298A1Methods and compositions for monitoring the treatment of relapsed and/or refractory multiple myelomaJANSSEN BIOTECH INC·Filed 2025·Application pending·0 cites
- 0759US2022373550A1Methods and compositions for monitoring the treatment of relapsed and/or refractory multiple myelomaJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 0857US2022267438A1Trispecific antibody targeting bcma, gprc5d, and cd3JANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 0955US6358707B1Human F11 antigen: a novel cell surface receptor involved in platelet aggregationSMITHKLINE BEECHAM CORP·Filed 1998·Granted Mar 19, 2002·13 cites·10 claims
- 1048US2022177584A1Methods for treating multiple myelomaJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kodandaram Pillarisetti files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →